Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cancer Related Cognitive Decline × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11735 Triple Negative Breast Neoplasms 1000 Neoplasms 676 Ovarian Neoplasms 587 Neoplasm Metastasis 527 Colorectal Neoplasms 510 Lung Neoplasms 509 Prostatic Neoplasms 493 Carcinoma, Non-Small-Cell Lung 474 Pancreatic Neoplasms 339 Melanoma 317 Stomach Neoplasms 307 Colonic Neoplasms 287 Breast Neoplasms, Male 260 Motor Activity 258 Carcinoma, Intraductal, Noninfiltrating 244 Head and Neck Neoplasms 234 Uterine Cervical Neoplasms 226 Endometrial Neoplasms 222 Carcinoma, Renal Cell 189 Sarcoma 180 Urinary Bladder Neoplasms 171 Squamous Cell Carcinoma of Head and Neck 169 Lymphedema 169 Esophageal Neoplasms 167 Breast Carcinoma In Situ 166 Brain Neoplasms 166 Fatigue 150 Carcinoma, Ovarian Epithelial 138 Breast Cancer Female 136

Interventions

pertuzumab 1 azeliragon 1 Trastuzumab 1 Docetaxel 1 Cyclophosphamide 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05256745 2025-12-24

RAGE

Georgetown University

Phase 1/2 Recruiting

Cancer Related Cognitive Decline

Data powered by HemOnc (CC BY 4.0) Colophon ⚡